The predictive and prognostic value of some routinely analyzed blood molecules were evaluated: CEA and CA 19.9 (commonly used cancer biomarkers), hemoglobin and platelets (promising hematological biomarkers in rectal cancer), and NLR and C-reactive protein (CRP) (systemic inflammatory response markers). Here, CRP is linked to rectal cancer.